mammalian target of rapamycin
Showing 1 - 25 of 8,953
Dietary Protein Trial in Saint Louis (Dietary protein shake)
Active, not recruiting
- Dietary Protein
- Dietary protein shake
-
Saint Louis, MissouriWashington University
Jan 29, 2023
Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer Trial in Miami (AI+CDK4/6i, SERD+CDK4/6i, mTOR inhibitor +
Not yet recruiting
- Breast Cancer
- +3 more
- AI+CDK4/6i
- +7 more
-
Miami, FloridaUniversity of Miami
Apr 12, 2023
Muscle Atrophy, Age-Related Sarcopenia Trial in Derby (Rapamune (sirolimus) 1Mg Tablet, Unilateral resistance exercise training)
Recruiting
- Muscle Atrophy
- Age-Related Sarcopenia
- Rapamune (sirolimus) 1Mg Tablet
- Unilateral resistance exercise training
-
Derby, United KingdomUniversity of Nottingham School of Medicine
Jun 7, 2022
Coronary Artery Disease, Coronary Stenosis Trial (Rapamycin target eluting stent)
Not yet recruiting
- Coronary Artery Disease
- Coronary Stenosis
- Rapamycin target eluting stent
- (no location specified)
Oct 13, 2021
Insulin Sensitivity Trial in Copenhagen (other, procedure, drug)
Recruiting
- Insulin Sensitivity
- Exercise
- +3 more
-
Copenhagen, DenmarkUniversity of Copenhagen
Jun 20, 2022
Coronary Artery Disease Trial in Worldwide (Microport Firehawk stent, 2nd generation DES (XIENCE family, Promus family,
Recruiting
- Coronary Artery Disease
- Microport Firehawk stent
- 2nd generation DES (XIENCE family, Promus family, Resolute/Onyx family/Endeavor, and Orsiro stent)
-
Birmingham, Alabama
- +56 more
Jul 25, 2022
Vitiligo Trial in Charleston (Rapamycin, Placebo)
Recruiting
- Vitiligo
- Rapamycin
- Placebo
-
Charleston, South CarolinaMedical University of South Carolina
Aug 2, 2022
Activated PI3K-delta Syndrome, Immunodeficiency Primary Trial in Shanghai (Rapamycin)
Recruiting
- Activated PI3K-delta Syndrome
- Immunodeficiency Primary
-
Shanghai, Shanghai, China
- +1 more
Mar 21, 2022
Acute Myelogenous Leukemia Trial in Rochester (Decitabine)
Completed
- Acute Myelogenous Leukemia
-
Rochester, New YorkUniversity of Rochester
Jul 1, 2022
Gallbladder Cancer Trial in Varanasi (Everolimus 10 mg, Standard of care)
Recruiting
- Gallbladder Cancer
- Everolimus 10 mg
- Standard of care
-
Varanasi, UP, IndiaBanaras Hindu University
Apr 18, 2023
Lymphangioleiomyomatosis, Tuberous Sclerosis Complex Trial in Boston ([11C]acetate)
Recruiting
- Lymphangioleiomyomatosis
- Tuberous Sclerosis Complex
-
Boston, MassachusettsBrigham and Women's Hospital
Jul 20, 2022
Bronchiolitis Obliterans Syndrome Due to and After Lung Transplantation (Disorder), Chronic Lung Allograft Dysfunction Trial in
Recruiting
- Bronchiolitis Obliterans Syndrome Due to and After Lung Transplantation (Disorder)
- Chronic Lung Allograft Dysfunction
- Sirolimus
- Placebo
-
San Francisco, CaliforniaUniversity of California, San Francisco
Aug 28, 2023
Healthy Nutrition Trial (resistance training, ketogenic diet, western diet)
Not yet recruiting
- Healthy Nutrition
- resistance training
- +2 more
- (no location specified)
Jun 8, 2023
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid
Active, not recruiting
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
- +9 more
-
Sewell, New Jersey
- +4 more
Dec 13, 2022
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) Trial
Completed
- Adult Acute Megakaryoblastic Leukemia (M7)
- +13 more
- Sirolimus
- +2 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Feb 2, 2023
Vascular Malformations Trial in Nijmegen (Sirolimus)
Active, not recruiting
- Vascular Malformations
-
Nijmegen, Gelderland, NetherlandsRadboudumc, HECOVAN workgroup
Jan 28, 2021
Peripheral Arterial Disease Trial (Rapamycin drug balloon angioplasty, Paclitaxel drug balloon angioplasty)
Not yet recruiting
- Peripheral Arterial Disease
- Rapamycin drug balloon angioplasty
- Paclitaxel drug balloon angioplasty
- (no location specified)
Aug 31, 2023
Vertebrobasilar Insufficiency Trial in Beijing (Drug-eluting stent)
Completed
- Vertebrobasilar Insufficiency
- Drug-eluting stent
-
Beijing, Beijing, ChinaBeijing Tiantan Hospital
Jun 11, 2020
Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Everolimus, Laboratory
Recruiting
- Advanced Malignant Neoplasm
- +3 more
- Everolimus
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 9, 2022
Classical Hodgkin Lymphoma Trial in Philadelphia (Itacitinib, Everolimus)
Active, not recruiting
- Classical Hodgkin Lymphoma
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Nov 28, 2022
Solid Tumor, Adult, NSCLC, Advanced Cancer Trial (Adagrasib, nab-Sirolimus)
Not yet recruiting
- Solid Tumor, Adult
- +4 more
- (no location specified)
Apr 24, 2023